These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 535124)

  • 1. Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.
    Lantz B; Adolfsson J; Lagerlöf B; Reizenstein P
    Cancer Chemother Pharmacol; 1979; 2(2):95-9. PubMed ID: 535124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL; Bonnet-Gajdos M; Mougenot B
    Arch Fr Pediatr; 1974; 31(7):697-704. PubMed ID: 4531839
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer.
    Pihkala J; Sariola H; Saarinen UM
    Pediatr Hematol Oncol; 1994; 11(3):259-69. PubMed ID: 8060810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study.
    Mir MA
    Br Heart J; 1978 Jul; 40(7):725-33. PubMed ID: 687469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J; Prochaczek F; Holowiecki J; Stella B
    Acta Haematol Pol; 1976; 7(3):195-8. PubMed ID: 983667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I; Ceranić LJ; Simeunović S; Cvetković P
    Bilt Hematol Transfuz; 1983; 11(2-3):51-7. PubMed ID: 6680300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac toxicity of rubidomycin. Apropos of 2 cases].
    Laine JL; Julienne O; Leroy J; Lamagnère JP; Laugier J; Desbuquois G
    Pediatrie; 1973 Mar; 28(2):201-10. PubMed ID: 4725976
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myocardiopathy from a new anthracyclic derivative (author's transl)].
    Montely JM; Gay J; Benoit P; Fontaliran F; Gerbaux A
    Ann Med Interne (Paris); 1979 Dec; 130(12):709-14. PubMed ID: 539690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline induced myocardial damage. An analysis of 16 autopsy cases.
    Kajihara H; Yokozaki H; Yamahara M; Kadomoto Y; Tahara E
    Pathol Res Pract; 1986 Aug; 181(4):434-41. PubMed ID: 3463940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of death in leukemia and lymphoma with modern treatment.
    Lantz B; Adolfsson J; Lagerlöf B; Reizenstein P
    Acta Haematol; 1980; 63(2):61-7. PubMed ID: 6768215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serial determination of anthracycline poisoning in children].
    Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H
    Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac damage in autologous bone marrow transplant patients: an autopsy study. Cardiotoxic pretreatment as a major risk factor.
    von Herbay A; Dörken B; Mall G; Körbling M
    Klin Wochenschr; 1988 Dec; 66(23):1175-81. PubMed ID: 3062267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Pericarditis in a case of early daunorubicin cardiomyopathy.
    Harrison DT; Sanders LA
    Ann Intern Med; 1976 Sep; 85(3):339-41. PubMed ID: 1066982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrocardiographic changes in patients with acute leukoses treated with rubidomycin or adriamycin at the Internal Clinic A].
    Avramović D; Stefanović S; Konecni J; Kovacević M; Ristić M
    Bilt Hematol Transfuz; 1976; 4(1-2):105-8. PubMed ID: 942366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.
    Jones RL; Miles DW
    Lancet Oncol; 2005 Feb; 6(2):67. PubMed ID: 15683815
    [No Abstract]   [Full Text] [Related]  

  • 19. A family with adult type ceroid lipofuscinosis (Kufs' disease) and heart muscle disease: report of two autopsy cases.
    Sakajiri K; Matsubara N; Nakajima T; Fukuhara N; Makifuchi T; Wakabayashi M; Oyanagi S; Kominami E
    Intern Med; 1995 Dec; 34(12):1158-63. PubMed ID: 8929641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.